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Resumo  
Este documento relata os trabalhos realizados dentro do escopo do projeto 
de conclusão do curso de Engenharia de Controle e Automção da Universidade 
Federal de Santa Catarina. Este projeto foi desenvolvido pela aluna Tatiana Beber 
Kassick durante seu estágio efetuado no seio da empresa Macopharma que projeta 
e produz equipamentos e dispositivos médicos. 
No setor de Pesquisa e Desenvolvimento em Automação da divisão de 
Transfusão, o projeto consistia em implementar um novo sistema embarcado para a 
máquina de iluminação de plaquetas sanguínias: a Macotronic UV. Esse aparelho 
permite a execução, o controle e o monitoramento do processo THERAFLEX UV-
Platelets. 
Plaquetas são componentes do sangue humano que, graças a seus efeitos 
coagulatórios, servem principalmente para estancar sangramentos e reparar vasos 
sanguínios danificados. Assim, transfusões de plaquetas são um tratamento 
altamente utilizado para prevenir hemorragias em pacientes com baixa 
concentração destes elementos.  
A partir de uma doação de sangue pode-se obter um concentrado de 
plaquetas ao separá-las dos outros componentes sanguíneos – glóbulos brancos e 
vermelhos – através de centrifugação. No entanto esse concentrado pode conter 
agentes patogênicos, como bacterias e virus, advindos do sistema do doador o que 
representa risco de contaminação e infecção para o paciente receptor. Glóbulos 
brancos remanescentes também podem causar reações adversas prejudiciais.  
Levando em consideração esses riscos e a fim de evitá-los ou ao menos 
reduzí-los signifivamente, diversas ténicas de inativação de patógenos já foram 
desenvolvidas. O processo THERAFLEX, elaborado pela empresa Macopharma, é 
um exemplo inovante nessa área. Ele utiliza luz ultravioleta de onda curta UVC 
(especificamente 254 nm de largura de onda), também chamada de luz germicida, 
para atingir diretamente os ácidos desoxirribonucleico e ribonucleico (ADN e ARN) 
patogênicos sem, todavia, afetar a estrutura plaquetária, importante para obtenção 
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de uma transfusão eficaz e bem sucedida. Para uma exposição uniforme, o 
processo THERAFLEX UV combina à iluminação um movimento rotatório da bolsa 
de concentrado de plaquetas, atingindo assim melhores resultados na inativação de 
patógenos.  
O processo é automatizado pela máquina Macotronic UV, composta por uma 
placa-mãe, uma placa de entradas e saídas analógicas gerenciada por um 
microcontrolador, um pirômetro, quatro fotodiodos, seis lâmpadas ultravioletas, 
motores, relés e ventiladores. Seu sistema embarcado compreende uma interface 
homem-máquina, um software para o microcontrolador e um protocolo de 
comunicação entre esses dois componentes.   
Apesar de já existir um protótipo deste dispositivo, uma revisão do seu 
sistema embarcado se fez necessária na busca por otimização do controle do 
processo, por um aumento de precisão durante a iluminação, por aprimoramentos 
em nivel de conforto para os usuários e para elevar a capacidade de manutenção 
dos códigos. O projeto descrito neste documento se dividiu, então, em três etapas: 
desenvolvimento de uma nova interface gráfica, alterações no programa do 
microcontrolador e adaptação do protocolo de comunicação às mudanças 
realizadas. 
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Abstract  
This document describes the development of a new embedded system for 
Macopharma’s Macotronic UV illumination device. Consisting of a human-machine 
interface application, a microcontroller software and a communication protocol 
between the two, this system aims to provide intuitive features and fully monitored 
process control, ensuring high level precision during the THERAFLEX UV-Platelet 
procedure to improve platelet quality and allow health providers to offer purer and 
safer platelet transfusion treatments. 
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Chapter 1. Introduction 
Platelets, also called thrombocytes, are a type of blood cell produced in the 
bone marrow whose main function is to stop bleeding and repair damaged blood 
vessels. Platelet transfusion is widely used to treat or prevent bleeding in patients 
with low platelet counts (due to diseases such as leukemia) or who have suffered 
massive blood loss (in case of injury, major operation or severe infection).  
When blood is donated, a platelet concentrate can be obtained by separating 
the platelets from the other blood cells, such as erythrocytes and leukocytes, 
respectively known as red and white blood cells. The platelet concentrate would then 
be transfused into another patient. However, as with every transfusion procedure, 
there are risks of infection if the originally donated blood was contaminated by 
bacteria and/or viruses. Furthermore there is the possibility of adverse reactions and 
immune responses if there are remaining leukocytes present in the platelet 
concentrate.  
To minimize these risks and extend shelf life of the platelets concentrates, 
many pathogen inactivation technologies (PITs) have been developed. Most of the 
PITs are based on adding a photosensitive compound to the platelet concentrate 
and activating it with ultraviolet lights in the UVB and UVA spectral regions, 
respectively wavelengths of 280 to 315 nm and 315 to 400 nm. This photosensitive 
compound, when activated, targets the nucleic acid of bacteria, viruses and 
leukocytes irreversibly damaging their DNA/RNA and consequently inactivating these 
pathogens. Although being an effective procedure, it requires a secondary filtering 
process to eliminate the added photoactive chemicals so as not to cause any toxicity 
in the platelet concentrate.  
The THERAFLEX UV-Platelets PIT, developed by Macopharma Enterprises, 
has the innovative advantage of using ultraviolet light alone to inactivate pathogens. 
Without the addition of any photosensitive agent, the filtering phase can be 
eliminated and the transfusion patients are spared the additional risk of exposure to 
a toxic element. 
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Based on the application of short-wavelength ultraviolet light (UVC: 
wavelength of approximately 254 nm), which is absorbed directly by the DNA/RNA 
nucleobases of the pathogens contained in the platelet concentrate, the 
THERAFLEX UV-Platelets is a rather simple procedure, proven highly effective in 
inactivating bacteria, viruses and residual white blood cells, while preserving platelet 
functions and quality. Optimal delivery of UVC light is attained when the illumination 
is combined with the orbital motion of the platelet concentrate bag which leads to 
uniform exposure. The procedure is performed by the Macotronic UV illumination 
machine that ensures a micro-processor controlled and fully monitored treatment of 
the platelet concentrate. 
 In summary, the Macotronic UV illumination device consists of an aluminum 
and stainless steel based structure, an LCD touch screen, a front panel door, an 
ejectable tray to place and agitate the platelet concentrate bag, six UVC lamps, a 
Central Processing Unit (CPU) board to run the user interface software and a 
Rabbit® microcontroller to manage motors, sensors and relays that are also part of 
the device.  
Within the Transfusion Division of Macopharma Enterprises, the goal of the 
project described in the present document was the development of a new embedded 
system for this equipment. Although the Macotronic UV and its embedded system 
already existed in a prototype version, the company decided it was time for a 
software revision to obtain control optimization, increase the illumination precision, 
improve user comfort and enhance maintainability. 
. 
1.1: Macotronic UV Project 
 
The embedded system for the Macotronic UV illumination device is composed 
of a Human-Machine Interface (HMI) application, a microcontroller program and a 
communication protocol between them.  
Originally programmed in C#, the software for the HMI application was entirely 
re-programmed in C++ because of the language’s better performance, portability 
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between different operational systems and the general programming tools it provides 
(multiple inheritance, pointers, class structure and macros). The Qt cross-platform 
library framework was used for its recognizable graphic designer tools as well as its 
simplicity, flexibility and robustness when developing user interfaces and deploying 
them in several targets. 
The existing microcontroller software was coded in Dynamic C: a C-like 
programming language for Rabbit®-based products. During this project the software 
was modified to include new features and solve known problems. In effect, the 
modifications extended to alter the operational procedure in order to convey more 
autonomy to the microcontroller. Whereas the previous version of the system 
handled the HMI and microcontroller in a master-slave capacity, the new system 
envisioned a more collaborative relationship.  
This significant increase in independence gives the microcontroller true 
dominium over its charges (motors, sensors and other actuators). It also transfers 
the responsibility to constantly verify the components states and identify hardware 
problems and/or components failure from the HMI to the microcontroller’s software. 
The new system dynamics leaves the HMI application to control more user based 
actions and reduces the back-and-forth of unnecessary commands.  
Nevertheless, there are still commands and requests that must be sent from 
the HMI application to the microcontroller and replies to be returned. To establish a 
line of communication compatible with the new operating mode the existing 
communication protocol was adapted.  
 
1.1.1: HMI Application 
 
A new graphic design was developed for the HMI in order to render the 
application more user-friendly. Its visual aspects also take into account a more 
standardized design so as to allow users to be familiar with many of Macopharma’s 
blood safety machines. 
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Providing the users with cycle management and monitoring, the HMI is the 
direct link with Macopharma’s clients and as such it is an important representative of 
the enterprise’s identity. The application has to be intuitive and simple to use while 
awarding the user with sophisticated screens and a wide variety of essential inlaid 
features. Launching the illumination cycle is, of course, the most important action a 
user can perform with the application.  
Once the cycle is launched the HMI displays on the screen information 
regarding the delivered light intensity, the platelet unit’s temperature, the agitation 
speed of the internal tray and the cycle’s duration. It also warns the user in case of 
errors before, during and after the illumination treatment. The application is also 
responsible for generating all the pertaining files, labels and reports at the end of 
each and every cycle. This ensures traceability, an attribute of great value in the 
health and blood products sector. 
 
1.1.2: Microcontroller Software 
 
As previously stated, the microcontroller software manages the machine’s 
actuators and sensors. While the original software performed all actions separately 
when directly commanded by the HMI application, the new program has a more self-
governing nature. In other words, in the former version, for each action to be 
executed there had to be a command issued from the HMI (e.g. open front panel 
door or turn ultraviolet lamps on), whereas in the modified version a single command 
can set off a succession of actions managed entirely by the microcontroller software.  
 One example of the implications of the past dynamics is that an illumination 
cycle represented a long list of commands and responses, with no sequencing of the 
clearly related actions. This affected the machine’s performance and contributed to 
increase communication derived errors. Provided that an illumination cycle has a 
very well defined and sequenced set of steps to follow and that neither the steps nor 
the sequence varies from cycle to cycle, there was no reason not to optimize the 
operational procedure.  
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The optimization enables the execution of all the actions pertaining to an 
illumination cycle after a single “Start Cycle” command is sent by the HMI. Upon 
reception of the command the microcontroller will close the front panel door, perform 
pre-cycle hardware tests, activate the tray agitation motor, turn UVC lamps on and 
execute regular hardware tests until the end of the cycle. The microcontroller’s 
program can identify on its own the end of the cycle by verifying the delivered light 
intensity. Once it reaches the ideal dose the treatment is considered completed and 
the software initiates the chain of events that determines the end of an illumination 
cycle, notably turning the ultraviolet lamps off, deactivating the tray agitation motor, 
opening the front panel door and ejecting the tray. 
Other modifications were made to better adapt the program to the new 
operational mode and to improve code readability and maintainability. 
 
1.1.3: Communication Protocol 
 
Considering the aforementioned requirements, the communication protocol 
had to accommodate several new commands. These commands and their overall 
structure were defined and documented. The protocol remained compatible with the 
previous versions of the microcontroller software so that once the prototype 
machines (that are in the field running clinical trials) are updated any discontinuity 
issues will be prevented.  
 
1.2: Document Structure 
 
The remainder parts of this document are organized as follows: 
 Chapter 2: presents Macopharma enterprises, its core divisions and 
associated products. The Research and Development activities within 
the Automation department are briefly described. 
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 Chapter 3: explores health and biological concepts and the blood 
products used along the present work. The THERAFLEX UV-Platelets 
procedure is explained to contextualize the problematic of the project.  
 Chapter 4: analyzes the programming tools, techniques and practices 
used for the development of the HMI application. The software 
architecture is examined as well as its individual modules. The 
implementation of the interface’s graphical elements is detailed.   
 Chapter 5: discusses the modifications made to improve the 
Macotronic UV device’s operating mode. The implementation of the 
automatic internal hardware tests is briefly approached. The 
commands included in the existing communication protocol and its 
basic structure are introduced to the reader. 
 Chapter 6: highlights the global results of the project and constructs a 
personalized opinion about the work done. 
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Chapter 2. Macopharma Enterprises 
Derived from the Vandeputte-Marchand wool product group, Macopharma 
was created as a result of a sudden need for diversification brought upon when new 
competitors based in Asia and North-Africa started to dominate the French textile 
market in the 1970s. At the same time, the blood transfusion field in France was 
undergoing a revolutionary transformation as the previously used breakable glass 
bottles were being replaced by durable plastic blood bags conceived by the 
American doctors Carl Walter and William P. Murphy, in the early 50s. 
Taking under consideration the textile sector’s difficult situation and in view of 
the opportunities arisen in the blood transfusion department, the Vandeputte-
Marchand group decided to invest in gathering medical and pharmaceutical 
professionals whose expertise would allow the production of blood bags.  
Macopharma Enterprises was, thus, officially founded in 1977 in Tourcoing 
France. The company profited from an accelerated growth rate and was soon able to 
innovate by developing and perfecting filters to reduce the presence of leukocytes in 
the blood bags. In parallel, it also started an intravenously injectable solutions line 
and had 620 thousand infusion bags leaving the plant in the first year of production.  
The next step was expansion. The 1990s were marked with product sales 
throughout Europe followed by the creation of several international subsidiaries. In 
2003, the FDA’s (Food and Drugs Administration) approval of one of Macopharma’s 
leukocyte reduction devices opened the door into the American market. New 
production sites were inaugurated in France, Poland and Tunisia to accommodate 
the growing demands with larger industrial output.  
When the World Health Organization issued an alert regarding the bird flu 
pandemic, in 2005, Macopharma, with its knowledge of high volume production, 
launched a new area of activity: respiratory masks. The production of masks 
intensified, going from 90,000 to 4 million units per week, following the 
announcement of the type A flu in 2009. In another front, as transfusion medicine 
evolved towards new cell treatments, Macopharma proceeded to diversify its 
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activities by developing biotherapy systems to contribute in the fields of regenerative 
medicine, transplantation and tissue therapy. With this initiative the four pillar 
divisions of the company were defined.  
With a global turnover of 171.3 million euros in 2014, over 2400 employees 
around the world and product presence in 88 countries [1], Macopharma is now a 
prominent international company, leader in transfusion, biotherapy, hospital devices 
and respiratory masks. In the coming years, it aims to reinforce its business and to 
stay attentive to new industrial and marketing opportunities which could contribute to 
its ongoing expansion, especially in high-growth areas like Brazil. Effectively, the 
group plans to extend its activities in Brazil by sharing knowledge in the blood 
product field and establishing partnerships with Brazilian companies, such as the 
local manufacturer of blood transfusion kits JPFarma, based in Ribeirão Preto, São 
Paulo.  
 
Figure 1 - Macopharma’s worldwide presence (Source: [1]) 
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2.1: Macopharma’s Business 
 
Throughout the years Macopharma has specialized in many activities 
associated with health care and blood products and services. The company has 
excelled and continues to seek advances in each of its core businesses through the 
work of its four main divisions. 
 
2.1.1: Transfusion 
 
As previously stated The Transfusion Division is responsible for the design 
and production of devices intended for the collection and preparation of blood 
components that meet high quality and safety standards. 
 
 
 
 
 
 
 
 
 
 
 
Figure 2 – Transfusion division (Source: www.macopharma.com) 
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Adaptable to each need, the blood collection systems represent safe and 
easy-to-use products for healthcare providers while assuring maximum comfort for 
blood donors. It consists of blood pack kits, automated blood mixers and tube 
sealers. The accessories provided with the blood bags in the pack kits prevent 
accidental needle stick injuries and enable sampling and blood testing, reducing the 
donation time and the risk of bacterial infection.  
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3 – Blood pack kit, the blood mixer Macomix and the Macoseal device  
(Source: www.macopharma.com) 
 
For blood processing, Macopharma offers a wide range of devices from 
leukocytes reduction filters to centrifuges and blood separators. In the blood safety 
front, innovative pathogen inactivation technologies like the THERAFLEX UV-
Platelets and the THERAFLEX MB-Plasma raises the safety margins by mitigating 
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contamination risks due to residual leukocytes and bacteria or viruses that may have 
gone undetected during initial screening.  
Avoiding the delays and costs pertaining to the development of new screening 
tests for emerging pathogens and different strains of known pathogens these 
procedures are considered a proactive approach of preemptive blood product 
treatment. 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4 – The Macospin centrifuge and a leukocyte reduction filter 
(Source: www.macopharma.com) 
 
2.1.2: Hospital 
 
The Hospital Division came to integrate the intravenously injectable solutions 
line with other products essential to infusion administration in patient treatment. The 
ample options of ready-to-use infusions include pain management solutions 
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(containing analgesics or anti-inflammatories), irrigation solutions (sterile water, 
glycocoll and sodium chloride) and anti-infectious diseases solutions (antibiotics, 
anti-parasitic or anti-fungal). 
 In addition to the solutions, several types of containers such as soft PVC and 
polyolefin bags are also supplied by the department. Needle-free connectors, 
protective sterile caps and other security and monitoring devices increase staff 
safety, reduce risk of double dosing and even allow the safe manipulation of 
hazardous medicaments used in chemotherapy. 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5 – Analgesic solution, safe connectors and polyolefin bag 
(Source: www.macopharma.com) 
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2.1.3: Biotherapy 
 
Macopharma’s investments in research and development have enabled the 
Biotherapy Division to conceive, develop and deliver cutting-edge solutions for each 
stage of cellular therapy, from collection, processing and treatment of cells to tissue 
or organ patient transplantation.  
In partnership with other leading biotechnology companies and with academic 
research teams in France, this division has had major break-troughs in the 
recuperation of stem cells (undifferentiated cells) from cord blood and bone marrow, 
the transportation, preservation and storage of tissue in low temperatures 
(cryofreezing) and the extracorporeal photo chemotherapy (ECP) to treat 
autoimmune disorder and transplant rejection. 
 
 
 
 
 
 
 
Figure 6 – The cord blood separator Macopress and MacogenicG2 for ECP treatment 
(Source: www.macopharma.com) 
 
In addition to enhancing the quality of cell collecting and graft preservation, 
the safe, ergonomic, high-performance medical devices facilitate biochemical clinical 
studies, essential to further advances in the biotherapy field.   
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2.1.4: Masks 
 
As one of the five official suppliers of respiratory masks for the French 
government, Macopharma provides highly efficient products that satisfy the most 
stringent requirements to manage epidemics and pandemics.  
 The Mask Division has expanded its portfolio to serve industrial users, 
business-to-business customers and especially healthcare providers. Its new range 
of surgical and pediatric masks with double certification delivers improved 
breathability while meeting both the highest industry standards and the needs of 
users. 
 
 
 
 
 
 
 
 
 
 
Figure 7 – General public, industrial and pediatric masks 
(Source: www.macopharma.com) 
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2.2: Research and Development in Automation  
 
The creation of cost-effective and high-quality automates meant the assembly 
of professionals with specialized knowledge in mechanical, electric-electronic and 
software engineering. Together these professionals compose a team of research 
and development in automation with the expertise to meet Macopharma’s needs and 
bring innovations into the field of medical devices.  
Rather than being an isolated division with a defined range of activities, the 
Automation department develops projects in constant collaboration with 
Macopharma’s primary sectors, notably the Transfusion, Hospital and Biotherapy 
divisions. In a sense, the divisions are the department’s clients and the department is 
the divisions’ supplier when it comes to automated machines.  
Through an open line of communication the aforementioned divisions provide 
the Automation department with the specification set that serves as project 
requirements for a new product or simply for a revision of an existing device. These 
requirements are a result of the exchanges between the divisions and their final 
clients.   
Each division has a direct relationship with its product consumers and profits 
from this relationship to gather information on user experience and client requests 
concerning the automated devices offered. The conduct of market research allows 
the divisions to single out their products’ eventual shortcomings or amelioration 
points. It also allows the identification of upcoming needs in their field.    
 The Automation department has its own direct contact with target consumers 
through installation, maintenance and support procedures. While the divisions’ dialog 
with the final clients focuses in the biological and health aspects of the services 
offered, the Automation department has a more technical approach due to the 
team’s background training. The additional information completes the specification 
list for new mission. Figure 8 shows a simplified scheme of how the Automation 
department is placed within Macopharma’s structure. 
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Figure 8 – R&D Automation (Source: own production) 
 
In addition to assembling user requests, the divisions’ verifies the regulations 
pertinent to the application in question. The rules and standards that must be 
respected in order to ensure the quality of the final product are also documented and 
passed to the Automation team. The resulting set of requirements is a project’s lead-
off.   
 
2.2.1: Project Life Cycle and Documentation Process 
 
The life cycle of a project consists of many steps. Each step is generally 
accompanied by an official document. The documentation process is essential to 
TRANSFUSION 
HOSPITAL 
BIOTHERAPY 
R&D 
AUTOMATION 
Macopharma’s Clients 
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ensure Macopharma’s quality standards. It also aids in proving project conformity to 
the applicable regulations and improves overall product maintainability. The diagram 
shown in Figure 9 summarizes a project’s work flow in macro phases. 
Aware of the specification set and the regulatory requirements, the 
development team will analyze the demands and define a list of functions to answer 
the requests. With these functions in mind, the system can be designed and its 
architecture determined. The modularization of the system is a well stablished 
practice, since it helps to organize the work and may even allow for the recycling of 
modules in other projects. The functionalities are allocated in modules according to 
their purposes.  
 
Figure 9 – Project life cycle and work flow (Source: own production) 
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All modules are then analyzed and a list of detailed requirements is 
elaborated for each one taking into account all its figuring features. The development 
and implementation of the modules is strongly founded in these specifications and, 
as such, it cannot take place without them. Once the modules are implemented, the 
chosen solutions are described and justified. Throughout the project’s life span there 
are validation stages to verify that the implemented features meet the specified 
requirements. 
In the diagram every transition represents an activity that results in a 
document containing the information described in the graph’s square boxes. The 
ellipses mark the validation phases where it is ascertained, by a documented test 
plan, if the developed features have attained their intended goals. In other words 
each specification document has its pair in a trial description that comprises all tests 
and results needed to validate the proposed solutions.  
Since the object of the present document revolves specially around the 
implementation stage (highlighted in orange in Figure 9) and focus on software 
rather than hardware development, it is worth noting that a simple and defined 
methodology is followed when it comes to this step. 
As each module is implemented separately, the software team makes use of 
Redmine, a project managing tool, to create tasks within the modules scopes and 
thus better organize and prioritize the work [12]. Deadlines for the tasks’ conclusion 
can be defined based on the project’s delivery time and on existing preconditions. 
This tool allows the team leader to assign the tasks according to personnel 
availability, experience level and any other criteria deemed of importance. The task’s 
responsible analyses and estimates a duration for its development. The tool also 
enables commentaries on the tasks’ progress and the allocation of man-hours which 
prove to be useful information for statistics and future estimations.  
Redmine calculates a Gantt chart to monitor the project overall advancement 
and connects with TortoiseSVN [13], a version control tool also used by 
Macopharma’s Automation department. In addition, every Monday the software team 
gathers to share information and the status on each current project. Together these 
tools and practices increase product and version security, the level of organization 
and the informational transit between team members.   
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Chapter 3. Blood, Blood Products and Services 
Blood is the life-maintaining fluid that circulates through the human body, 
regulating body temperature, transporting nutrients and oxygen to the cells and 
carrying off carbon dioxide, ammonia and other waste products for filtering in the 
lungs, kidneys and liver. Other critical functions are forming blood clots to help the 
cicatrization process and conveying cells and antibodies to fight infection.  
A typical 70 kg adult has a total blood volume of approximately 5.5 liters. This 
volume varies depending on height and weight of a person as well as his/her state of 
hydration. The blood is composed mainly of erythrocytes (red blood cells), leukocytes 
(white blood cells), thrombocytes (platelets) and plasma. 
 
Figure 10 – Blood Components (Source: Google Images) 
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3.1: Erythrocytes (Red Blood Cells) 
 
Known for their bright red shade that gives the blood its characteristic color, 
erythrocytes, commonly called red blood cells, are the most abundant cells present 
in the blood stream, accounting for 40 to 45 percent of its total volume. 
 
Figure 11 – Microscopic view of Erythrocytes or Red Blood Cells 
(Source: Google Images) 
 
Shaped as biconcave disks, these cells have no nucleus which renders 
flexibility to fit through the various sized blood vessels within the human body. The 
lack of nucleus also contributes to accommodate maximum space for hemoglobin, a 
special iron containing protein that binds with oxygen. When the erythrocytes, 
traveling in the blood, reach the body’s tissues and organs this biomolecule releases 
the oxygen allowing cellular aerobic respiration to take place thus fueling metabolic 
functions. The red blood cells are produced in the bone marrow and have a life span 
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of about 100 to 120 days in the circulatory system before their components are 
recycled by phagocytosis [2]. 
 
3.2: Leukocytes (White Blood Cells) 
 
Leukocytes, also called white blood cells, are the body’s first and foremost line 
of defense. They protect against bacterial, viral, parasitic and fungal infections, 
allergies, tumors and other diseases by identifying and attacking foreign agents. 
Deriving from a cell produced in the bone marrow that has the potential to 
differentiate, leukocytes present in many types each one specialized in different 
immunological functions. All leukocytes, however, have a nucleus, distinguishing 
them from red blood cells and platelets.  
 
 
 
 
 
 
 
 
 
 
Figure 12 – Microscopic view of Leukocytes or White Blood Cells 
(Source: Google Images) 
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In addition to circulating in the blood, these cells are found in other tissues 
throughout the body, notably the spleen, liver and lymph nodes. In case of injury or 
infection they are quickly mobilized to the affected area. They are also responsible 
for the removal of the dead red cells remains by phagocytosis, as mentioned in the 
previous section.  
Although a reassuring presence in most cases, white blood cells can cause 
autoimmune disorders (when the body’s immune system attacks and destroy healthy 
cells by mistake) and graft-versus-host disease (when the transplanted tissue’s 
leukocytes recognize the recipient’s cell as foreign and tries to neutralize them, 
causing transplant rejection) [3]. 
White blood cells represent less than 1 percent of total blood volume and 
have a short life expectancy of 18 to 36 hours [2]. The number of leukocytes in the 
blood is often an indicator of disease: an elevated proportion generally suggests 
infection.  
 
3.3: Thrombocytes (Platelets) 
 
Unlike erythrocyte and leukocytes, thrombocytes, most simply named 
platelets, are not actually cells but rather small cell fragments. They do not possess 
nucleus and are about 20 percent smaller than the red blood cells. Along with clotting 
factors (chemical compounds in constant circulation in the blood), the platelets’ main 
functions are to prevent bleeding and repair damaged blood vessels.  
Being lighter than other blood components, they are forced from the center of 
the blood flow to the walls of the blood vessel. The surface of the walls is lined by 
endothelium cells that stop any agents from attaching to the duct. If an injury causes 
a tear or a cut in the endothelium layer, however, a signal is sent and the platelets 
are activated, changing from their normal plate form to a star or octopus-like shape, 
with long extended filaments, or tentacles, and adhering to the broken region. They 
cluster together providing an initial seal and marking the start of blood coagulation. 
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The result of this process is a fibrous clot which covers the wound and forms a 
platform upon which new tissue is woven promoting healing. 
 
Figure 13 – Thrombocytes or Platelets in their inactive (left) and active (right) forms 
(Source: Google Images) 
 
Platelets disorders are well known in the health department. High platelet 
count can cause spontaneous clots and consequently heart attacks and strokes. Low 
platelet count is characterized by easy bruising and frequent and/or excessive 
bleeding. 
 
3.4: Plasma 
 
The liquid component of blood is called plasma: mostly water (92%) with a 
mixture of sugar, fat, protein and salts. It presents as a yellowish fluid and it 
constitutes approximately 55 percent of total blood volume. It mainly serves as a 
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conduit to transport blood cells through the body along with nutrients, waste 
products, antibodies, clotting compounds, chemical messengers, such as hormones, 
enzymes and proteins that help maintain the body's fluid balance. 
 
Figure 14 – Plasma bag (Source: Google Images) 
 
3.5: Pathogens and Antigens  
 
The human body is a complex and intricate ecosystem where cells co-exist in 
symbiosis with bacterial, fungal, and protozoan species. These microbes are part of 
the normal flora and usually aid in essential body functions (e.g. lactobacillus 
bacteria in the digestive system help the body to absorb nutrients and balance the 
intestine’s pH level). Nevertheless they may cause damage in abnormal conditions, 
in case of immune deficiency or injury. In addition, humans are always infected with 
viruses, most of which, however, rarely become symptomatic.  
Pathogens are all foreign microorganisms that, in contrast with the normal 
flora, cause diseases when introduced in the human body. They are bacteria, 
viruses, protozoa and fungi specialized in infecting a host, avoiding its innate 
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immunological system, multiplying and spreading to new hosts. It is argued that the 
responses they induce from their hosts (e.g. cough, diarrhea or bleeding) are part of 
the strategy to enhance their propagation. Figure 15 shows various types of illness-
inflicting pathogens: 1) the Ebola virus; 2) C. gatti fungus that causes Cryptococcocal 
disease; 3) Human Immunodeficiency Virus (HIV) that can lead to Acquired Immune 
Deficiency Syndrome (AIDS); 4) Dengue virus; 5) Giardia intestinalis protozoan 
parasite that causes Giardiasis; 6) Streptococcus bacteria may cause meningitis.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 15 – Microscopic view of various Pathogens  
(Source: Google Images) 
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An antigen is a substance that triggers a response from the immune system. 
Leukocytes can identify these substances as hostile and foreign, thus setting off 
chain reactions for the defense mechanisms. They are often found on the surfaces 
of pathogens.  
 
3.6: Platelet Concentrate Transfusion  
 
Having presented the importance of platelets in the coagulation process, it is 
easy to understand why platelet transfusion is increasingly being used to treat or 
prevent bleeding in patients with low platelet counts (due to diseases such as 
leukemia) or who have suffered massive blood loss (in case of injury, major 
operation or severe infection).  
The platelet concentrate is generally obtained from the buffy coat layer formed 
when whole blood (i.e. donated blood with all its components) undergoes 
centrifugation.  Due to their distinct densities, the different constituents separate from 
one another in three visually identifiable phases as shown in Figure 16. The buffy 
coat, so called for its yellow-brown color, contains most of the white blood cells and 
platelets. 
 
Figure 16 – Blood Separation by Centrifuge (Source: Google Images) 
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Following the centrifugation, the heterogenic blood bag is transferred to a 
press machine that physically separates each layer into different bags. Since the 
buffy coat represents a very small portion of the donated blood, four to six bags need 
to be pooled together in order to allow for platelet transfusion. These bags generally 
originate from multiple blood donors. Although there are donation procedures that 
enable the collection of an acceptable quantity of the buffy coat from one single 
donor, they generally imply a long collection time (up to 12 hours), which represents 
a more arduous procedure for the donor. In most cases the pooling process is 
preferred in view of its simplicity, shorter collection time and lower costs.  
As previously stated, the buffy coat has a high concentration of white blood 
cells as well as platelets. Therefore a leukocyte reduction must be performed. 
Ultimately the platelet concentrate is the result of passing the contents of a buffy coat 
bag through a leukocyte-deletion filter.  
 
3.7: The THERAFLEX UV-Platelets Procedure  
 
The main problematic for platelet transfusion is maintaining platelet quality at 
high levels throughout the preparation and storage of platelet concentrates. In fact, 
the availability of these concentrates is restricted by their short shelf lives due to two 
major interconnected issues: pathogens and leukocyte contamination and storage-
related deterioration known as platelet storage lesion (PSL).  
As with all transplant and transfusion procedures, there is always the risk of 
contamination by pathogens that may be present in the donated tissue (in this case, 
the donated blood). Remaining white blood cells can also cause grievous reactions 
to the transfused patient as explained in Section 3.2:. The pooling process briefly 
described in the previous section and most commonly used for concentrating 
platelets increases the risk of bacterial/viral infection as well as leukocyte immune 
responses since the transfusion bag is obtained from multiple donors.   
In parallel, PSL, best defined as harmful changes in platelet structure, can 
occur between the time of blood collection and the time the platelets are transfused 
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into a patient, greatly affecting transfusion outcome. The preservation of platelet 
morphology, composition and function is essential to positive transfusion reactions 
and a successful treatment. In other words, platelet proprieties that render treatment 
efficacy cannot be lost in the process of obtaining, preparing and storing the 
transfusion bags.     
Both of these issues are intrinsically related and one cannot be addressed 
regardless of the other. A balance between reducing pathogen and leukocyte 
contamination and maintaining platelet quality and function must be considered when 
trying to produce purer and safer platelet concentrate with extended shelf life. In the 
last decade, much progress has been made in this front with the development of 
pathogen inactivation technologies (PITs).   
The THERAFLEX UV-Platelets, developed by Macopharma, is an innovative 
PIT that uses shortwave ultraviolet light to inactivate pathogens and residual white 
blood cells. Based on the well-established sterilization capacity of the UVC light, for 
this reason also called germicide light, the procedure causes maximum damage to 
bacterial and viral DNA/RNA with little-to-none platelet deterioration. This is the result 
of UVC light application at a wavelength of 254 nm which closely coincides with the 
highest absorption range by pathogens’ nucleic acids (approximately 260 nm) and 
minimum absorption by platelet proteins [4], as shown in Figure 17. 
Optimal delivery and penetration of UVC light is attained when the illumination 
is combined with the orbital motion of the platelet concentrate bag which leads to 
uniform exposure. 
Although most PITs employ ultraviolet illumination, notably with UVB and UVA 
lights (wavelength range from 280 to 320 nm and from 320 to 400 nm respectively), 
the THERAFLEX UV is the only procedure that does not require the addition of a 
photosensitive agent to target pathogenic DNA/RNA. This singular characteristic 
represents a great advantage compared to other technologies since it eliminates the 
need to filter the added photoactive compound in order to prevent chemical 
contamination and toxicity of the platelet concentrate. It renders simplicity and 
security to the pathogen inactivation procedure.     
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Figure 17 – Absorption Spectrum for Pathogen DNA/RNA and Platelet Proteins 
(Source: [4]) 
    
 Many studies and clinical trials have been conducted to evaluate and validate 
this PIT. Through these tryouts the THERAFLEX UV-Platelets has proven to be 
highly effective in inactivating bacteria, viruses and residual white blood cells, while 
preserving platelet functions and quality [4]. 
To perform the THERAFLEX UV-Platelets procedure Macopharma has 
developed the Macotronic UV illumination device shown in Figure 18. The platelet 
concentrate is transferred into a special new-generation illumination bag, part of the 
processing kit also provided by the company (Figure 19), and inserted in the machine 
for treatment. The platelet unit is then agitated and exposed to the UVC light 
(double- sided illumination) for less than one minute. The procedure is fully controlled 
and monitored by the device’s embedded system. The system communicates with 
printers to produce reports and identification labels in order to ensure product 
traceability and correct documentation. 
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Figure 18 – The Macotronic UV illumination device (Source: [10]) 
 
After the completion of the treatment the platelets are transferred to the 
storage bag of the processing kit and can be released for transfusion with no further 
processing. In total, the whole operation takes less than 10 minutes, most of that 
time represented by the two pack transfers, which allows platelets products to be 
treated and released in the same day [4]. 
 
 
 
Figure 19 – The THERAFLEX UV-Platelets process 
(Source: www.macopharma.com) 
 
(a) 
(a) (a) 
(b) 
(b) (b) 
Processing kit Processing kit Macotronic UV 
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3.8: The Macotronic UV  
 
Briefly explained, the Macotronic UV illumination device consists of an 
aluminum and stainless steel based structure, a LCD touch screen, a front panel 
door, an ejectable tray to place and agitate the platelet concentrate bag, six UVC 
lamps, a CPU board and a Rabbit® microcontroller.  
The CPU board runs the Human-Machine Interface (HMI) application and the 
microcontroller operates under a Dynamic C program to control the machine’s 
motors, sensors and relays. Both of these software components exchange 
information via a communication protocol. Together they compose the device’s 
embedded system. Although such a system already existed for the machine’s 
prototype, a complete revision was performed and a new version was developed and 
released. The implementation of this new version is the focus of this document and 
will be further explored in the following chapters.  
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Figure 20 – Macotronic UV’s basic structure (Source: own production) 
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Chapter 4. Macotronic UV: HMI Application 
The Macotronic UV’s LCD touch screen allows users to interact with its 
embedded HMI application and, through it, launch and monitor the THERAFLEX UV 
Platelets procedure. The application also provides users with data management and 
product traceability. 
During clinical trials of the THERAFLEX UV-Platelets procedure the 
Macotronic UV prototyped version was used by many potential future clients. Since 
the HMI is a direct link with Macopharma’s clients and as such serves as a 
representation of the company’s identity, user feedbacks concerning the application’s 
visual layout was greatly considered in the development of a new graphic design. 
Focusing in intuitiveness, the new application is user-friendly and simple to 
use. Its modern visual aspects also take into account a more standardized design so 
as to allow users to be familiar with many of Macopharma’s blood safety machines.  
Originally coded in C#, the HMI software was entirely re-programmed in C++ 
in view of the language’s better performance rates, portability between different 
operational systems and the general programming facilities it provides (multiple 
inheritance, pointers, class structure and macros).  
Throughout the project, all HMI programming was accomplished with the Qt 
Creator Integrated Development Environment (IDE) [14]. This IDE offers tools that 
facilitate the application development. Some of these tools were an exact match to 
the project needs concerning graphic, flexibility and robustness requirements.  
Qt Designer [15], for instance, is a tool that aids in constructing Graphic User 
Interfaces (GUIs) by providing a visual editor where the developer can compose and 
customize widgets and dialogs. Another example is the Qt Linguist tool [16]: an 
excellent support for translating applications into local languages, an aspect of great 
importance since Macopharma’s client network expands internationally. Furthermore, 
the qMake tool [17] simplifies the building process across different target platforms, 
which will allow future development and deployment of mobile operating systems 
such as Android and iOS. 
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This chapter explores the implementation of the HMI software which runs in 
the Central Processing Unit (CPU) under the MS Windows 7 Embedded Operating 
System (OS) its new graphic design, essential inlaid features and added 
functionalities such as the user management and machine configuration tools. The 
theoretical basis for the development will also be briefly reviewed. 
 
4.1: Model/View Programming 
 
To better organize the HMI application and increase modularity and 
maintainability, the model-view-controller (MVC) architectural pattern was adopted. 
Widely favored when designing user interfaces, this structure divides the software 
into three interconnected parts [6], as shown in Figure 21, separating the 
representation of internal information from the way that information is displayed to 
the user. 
The Model layer represents the knowledge of the application. It implements 
the business logic. It is responsible for storing or retrieving information from an 
external data source; for converting it into meaningful concepts to the application; for 
processing, validating and for any other tasks related to data handling. In other 
words, it defines the application’s behavior.  
The View layer is the screen presentation of the modeled data. It receives 
treated information from the Model layer and displays it to the user in customized 
ways. It acts basically as a presentation filter, highlighting certain attributes while 
suppressing others. It does not own and therefore cannot alter the core data since 
that is the Model’s domain. A view item needs to be associated with a model in order 
to properly function, to show the appropriated information. 
The Controller layer defines the way the interface reacts to user input. With 
the aid of both Model and View layers it handles user requests rendering an 
appropriate response either modifying a model’s state or updating a view. In doing so 
it represents the link between user and application. 
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Figure 21 – Simplified diagram of model-view-controller architecture 
(Source: Google Images) 
 
Slightly adapting the MVC pattern to simplify the structure while maintaining its 
principles, the Qt framework combines view and controller objects. This junction 
means that, in addition to managing overall layout of data presentation, View classes 
have embedded controllers to handle item navigation, selection and edition. They 
can also make calls to Model classes to launch a desired behavior. Qt provides 
abstract classes for the Model and View layers that can be subclassed in order to 
create specialized components and attain the full set of functionalities needed for 
each application [5]. These objects communicate using the signal and slot 
mechanism, a central feature of Qt which is explained in the following section. 
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4.1.1: Signals and Slots 
 
The signal and slot mechanism can be perceived as a cause and effect 
reaction. When an object suffers a change in its state that may be of interest to other 
objects it can be said that an event occurred. In light of this event, a signal is emitted. 
A slot is a function that is called in response to a specific signal to which it is 
connected. Hence, a slot can be considered the effect of the cause represented by 
the signal. For example, if a Close button is pressed in a dialog window (cause), a 
close() function may be called to perform the action of closing the dialog (effect).  
One signal can be connected to as many slots as needed and vice-versa. A 
signal can also be connected to another signal, implying that when the first is 
received, the second will be immediately emitted. Nevertheless, signals and slots are 
loosely coupled. In other words, the object that emits a signal is not aware if a 
recipient exists and/or which slot or slots are connected to the signal. In the same 
way, a slot does not require knowing if it is connected to any signals or to which 
signals in particular. It can be used as a normal function. This system enables data 
encapsulation and ensures that truly independent software components can be 
created with Qt. 
 
 
 
 
 
 
 
 
Figure 22 – Signal and Slot connections (Source: Google Images) 
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When a signal is emitted the slots connected to it will be executed 
immediately and independently of any GUI event loop, as would any regular function. 
The execution of various slots connected to the same signal follows the order of the 
connections: the first slot connected will be the first executed. The tasks programed 
after the emission of the signal will occur once all slots have returned. Queued 
connections can be used to alter this behavior so as to carry out the tasks following 
the emission of the signal before the execution of the connected slots.  
Signals and slots can take any number of arguments of any type. However, 
the signature of a signal must match the signature of the connected slot to ensure 
type safety. In fact, a slot may have a shorter signature than the signal it receives 
because it can ignore extra arguments, but the opposite cannot occur. Since the 
signatures are compatible, the compiler can help detect type mismatches when using 
the function’s pointer-based syntax [5].  
As previously stated slots are regarded as normal functions. Thus they can be 
called directly by any object with the right access level. They follow the regular C++ 
rules and can be defined as virtual, which can be useful when subclassing widgets. 
When considered in a signal-slot connection, however, the slot may be invoked by 
any component regardless of the access level. This means that a signal emitted from 
an instance of an arbitrary class can cause a private slot to be invoked in an instance 
of an unrelated class. 
Qt offers a variety of default widgets with predefined signals and slots, but it is 
common practice to subclass these widgets, customizing signals and slots to serve 
the application’s needs. Indeed, the Macotronic UV application was founded on 
subclassing the base user interface class QWidget. 
 
4.2: Graphic Design 
 
This section focuses in the graphic design of the application or its View layer. 
The user interface is a composition of screens. Every screen corresponds to a top-
level item of the View layer and thus is a class always named with the suffix “View”. 
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For instance, the class associated with the screen that appears at the machine’s 
start-up is called InitializationView. All the views derive from a superclass View that in 
turn inherits from Qt’s QWidget class. This class is the bedrock for the View layer 
since it receives mouse, keyboard and other events from the window system and 
paints a representation of itself on the screen. 
The window system is the platform onto which the GUI’s composition is build. 
Inheriting from QMainWindow (also a subclass of QWidget) the MainView class 
represents the founding visual element of the HMI. It is the primary widget and, as 
such, it is not embedded in a parent widget but rather serves as a parent for all other 
views. In other words, it is a canvas for the application’s screens to be portrayed in. 
Figure 23 shows a simplified relational diagram between the aforementioned 
classes. 
 
Figure 23 – View Layer (Source: own production) 
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Designed with Qt Creator’s visual editor, this elementary component is divided 
in three parts: a central area where most of the information is displayed; a horizontal 
bar at the bottom where action buttons are arranged according to the application’s 
needs; and a vertical bar at the right side where other interactive and informational 
items can be placed. Figure 24 shows the main view (in red) in its “undressed” form 
with its basic components highlighted (the bottom widget in green and the right 
widget in black).  
 
 
 
 
 
 
 
Figure 24 – Main View design (left); Bottom and Right Bars Views (right) 
(Source: own production) 
 
The encapsulation of widgets adds flexibility and allows the use of multiple 
views at the same time. In this case, three views can be used simultaneously, each 
in a specific area of the main view. This does not mean, however, that three views 
must always compose the main window. The BottomBarView and the RightBarView, 
generic widgets presented in Figure 24, are combined with different bigger views 
(placed in the central area). They are programmed to provide certain basic features 
needed in various stages of the application. The BottomBarView integrates buttons 
to trigger specific actions and the RightBarView assembles a virtual numeric 
keyboard (among other minor services).  
MAIN VIEW 
BOTTOM WIDGET 
RIGHT  
WIDGET 
BOTTOM BAR VIEW 
RIGHT  
BAR 
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As each application state has its particular set of actions to perform, its view 
can make use (or not) of one or both the aforementioned views. Figure 25 illustrates 
an example: during the login of a user by password, the RightBarView’s virtual 
keyboard is used as an input tool and appears over the main view’s background 
image (picture in light blue). On the other hand, if the user identification is via a 
scanned barcode the RightBarView is not required and consequently does not 
appear, leaving only the background image at the right side of the window. 
The modularization of these objects enables the repeated use of the same 
views when identical, or similar, services are demanded in different steps of the 
operation. To manage their behavior, as explained in Section 4.1:, they are 
associated with the Model layer having each a model to communicate to: 
BottomBarModel and RightBarModel respectively. Their generic programming 
anticipates the need for customization of the functionalities they offer. For instance, 
the virtual keyboard previously referenced can be reused in different screens with 
different character options than that of the LoginView. The buttons provided by the 
BottomBarView may vary in visual aspects according to the currently required 
services. It can be seen in Figure 25 that both images contain a button in the middle 
of the bottom bar, but the icon changes to specify the action that will be trigger if the 
button is clicked (a barcode scan on the first image and a password entry on the 
second to represent a change between the methods of user identification).    
 
 
 
 
 
 
Figure 25 – Login Views: by password (left) and barcode scan (right) 
(Source: own production) 
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It can also be observed that although the BottomBarView offers multiple 
buttons (as shown in Figure 24) only one is needed for the user identification views. 
Employing a specific number of BottomBarView’s widgets is another way its services 
can be customized. Beside their quantity, the position of the buttons can likewise be 
chosen. Figure 26 presents another screen shot, where the Add, Edit, Delete and 
Save buttons are depicted.  
Regardless of the customization, this design organizes the screens so that the 
user will always know to find the right tools in the right places: the action buttons will 
always be located in the bottom of the screen no matter their role and appearance 
while the keyboard will always be set in the right side no matter what characters it 
shows. Increased coherence and constancy was a point made by client feedback to 
improve the overall simple-to-use quality of the application when compared to the 
preceding software.    
 
Figure 26 – User Management View (Source: own production) 
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Another important element from the View Layer is the GenericPopupView. It is 
meant to draw the user’s attention to an important message by jumping or “popping-
up” over the main view. Much like the BottomBarView and the RightBarView and as 
it can be inferred by the class’s name, it is recycled to serve in many situations, 
notably to show error warnings of various types. Even though the information 
communicated may change, the presentation remains basically the same: a 
translucent caution themed band superimposing the current screen leaving it with a 
blurred effect (Figure 27). It can also provide the Yes, No and Ok buttons depending 
on the problem and if a solution is offered for user validation.  
 
Figure 27 – Generic Popup View (Source: own production) 
 
The imagery – background pictures, icons, colors – selection was as much a 
part of the HMI’s development as the views’ programming. Some items were 
recovered from other recent projects to attempt at a standardization of the blood 
safety devices. The idea is that clients who acquire several different blood treatment 
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machines will be familiarized with the embedded applications if the devices share a 
similar graphic design, easing the clients’ adaptation process. Many items however 
were specially chosen for the Macotronic UV’s user interface and are, for the 
moment, only present in this project. The overall goal of the imagery selection was 
giving the application a simple, but modern look, easy to comprehend and operate. 
    
4.3: Application Modules 
 
Looking to the future, Macopharma’s Automation department envisions many 
home-made software releases for its current and forthcoming machines. Considering 
that all the company devices have not only unique features but common features as 
well – such as user identification process, data management and machine 
configuration – the concept of a generic platform with recyclable non-specific 
modules is greatly valued. 
Favoring this line of thought the HMI software was conceived in a modular 
structure. Without rendering operational details for each feature, Figure 28 shows the 
application’s major modules. Through the image, it is evident that there are many 
modules that could be reused for other devices, providing the same services only 
with different core information.  
With this organizational architecture in mind, the common modules were 
programmed seeking generalization so that the codes could eventually come to 
integrate a universal base from where future devices would retrieve certain 
fundamental features to compose their application. However, other than anticipating 
the possibility, this project has not further participated in the realization of a universal 
platform.   
To provide its main function each module is composed of both Model and 
View layer elements. Every view item is connected to at least one model to obtain 
the information it needs to present on the screen. More often than not, a view 
communicates with multiple models, since complex features require data from many 
different sources. As an example, the simple module that allows users to reprint a 
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report or a product label concerning an illumination cycle comprises a view 
associated with several models (Figure 29). It must not be overlooked that the 
module also employs the BottomBarView and the GenericPopupView, along with 
their respective models to make use of their services as described in Section 4.2:. 
 
Figure 28 – HMI’s operational modules (Source: own production) 
 
Every time an illumination cycle is executed its data is stored in a history file.  
It is based on this data that the reports and product labels are generated. The 
CycleHistoryModel manages all existing history files and is needed to perform a 
search given the intended cycle’s bag code. Once the appropriate cycle file is found, 
the user can select it and press on the Report or Label button from the ReprintView 
(Figure 30 on the left) – provided by the BottomBarView – choosing to print the 
associated report or label respectively.   
Receiving the user’s choice as an input, the ReprintView will convey a 
command to the ReportModel or the LabelModel that, in turn, will compile and format 
the pertinent information from the history file into a report or a label and will 
subsequently sent it to the specialized printers connected to the Macotronic UV. If 
there are no files corresponding to the entered bag code, a warning message 
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appears to the user as it can be seen on the right in Figure 30 (service from the 
GenericPopupView). 
 
Figure 29 – Reprint Module components (Source: own production) 
   
 
 
 
 
 
 
Figure 30 – Reprint View (left) and warning message (right)  
(Source: own production) 
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Other modules utilize the above referenced models as well. Models are 
islands of specific information that can be accessed by different agents in different 
moments of time, avoiding code repetition and data duplication. Since they 
monopolize and concentrate all information belonging to their particular functions, 
when that information is modified by an operation there is no risk of coherence or 
synchronization problems: all other modules are sure to receive the correct updated 
data.  
The Reprint module is but a sample used in this document to illustrate the 
dynamics between the Model and View layers and corroborate the presumed 
advantages of this pattern. As it provides unpretentious functionalities (printing 
arranged information) it was not included in Figure 28’s diagram of the HMI’s main 
features. The following sections explore a few of the modules’ development focusing 
on some worth-to-mention implementation details.   
 
4.3.1: User Management Module 
 
As already remarked, the Macotronic UV illumination device is protected by a 
user identification system which is managed by the HMI. When a client acquires one 
of these machines it is necessary to register a list of authorized users: login names, 
passwords, badge code and access level. Once this list exists, any of its members 
can log in using the appropriate entry information.  
While the previous version of the application did verify and validate a login 
before admitting a user to operate the device, it lacked a feature to add, edit and 
exclude users from this list. Macopharma’s technicians had to register all approved 
users during the installation of the machine via an external tool. It was a procedure 
both ponderous and prone to misspells. Outside the application the technician could 
unknowingly misplace or disarrange configuration and/or dynamic-link library files 
(DLLs) causing other and more serious problems.  
Eliminating the need to exit the application to access an external tool, the new 
HMI, integrates a user management module thus facilitating the task for 
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Macopharma’s technicians. This module also allows the direct handling of the access 
list by an Administrator-level client user.  
The UserManagementView presents the registration list in the form of a two 
column table (Figure 26). The first column contains the user name and the second 
the access right (either Administrator or Operator). The Add, Edit and Delete buttons 
enable the administration of the list. When an existing user is selected and the Edit 
button, circled in green in Figure 31, is pressed the highlighted line will extend to 
show four editing fields and an option box in the following order: login name, 
password, password confirmation, barcode ID and access level. This expanding tree 
effect, shown in Figure 31, was chosen to display user information after careful 
consideration.  
Impossible to ignore, the screen’s small size demanded a study of how to best 
exhibit the editing fields in a clean and effective way. Once again, client feedback 
was taken into account. The screen’s tactile and overall esthetic characteristics when 
scrolling horizontally where deemed inferior to when scrolling vertically. Also, seeing 
that, when distended, the selected line will “push” all other lines the need to scroll at 
all (in this case vertically) will be less frequent to say the least.   
 
 
 
 
 
 
 
 
Figure 31 – User Management View in editing mode 
(Source: own production) 
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Other modules could come to profit from this design. Bearing that in mind, the 
mother classes GenericTreeView and GenericTreeModel were created to provide, as 
their names specify, the generic services of listing items in a table-like manner with 
built-in tree behavior and of handling those items via action buttons from the 
BottomBarView. The UserManagementView and the UserManagementModel inherit 
from these super-classes and connect with the LoginModel to recover the user 
information needed to fill in this table-and-tree fashioned container. Figure 32’s 
relational diagram portray the major components of the User Management module. 
 
Figure 32 – User Management module (Source: own production) 
 
The GenericTreeView class has two constructors: one that requires no 
arguments and another that demands the name of a model and a view (Table 1 - line 
1). The view name builds the current view in the View constructor (Table 1 - line 2), 
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while the model name serves to find the appropriated model object (Table 1 - line 4). 
Therefore, every tree view subclass is constructed using its own name and the name 
of its associated model in these roles, as exemplified by the UserManagementView 
illustrated in Table 2. This allows for the communication between the view and the 
model indirectly – represented by the dotted line in Figure 32 – and eliminates the 
need to declare another model as a member of the view class.  
GenericTreeView definition 
001 GenericTreeView(string modelName, string viewName) :  
002 View(viewName) 
003 { 
004            a_pGenericTreeModel = a_pModelFactory->getModel(modelName);  
005            … 
006 } 
Table 1 – GenericTreeView class definition 
UserManagementView definition 
001 UserManagementView() : 
002 GenericTreeView (“UserManagementModel”, “UserManagementView”) 
003 { 
004 a_pLoginModel = a_pModelFactory->getModel(“LoginModel”); 
005            … 
006 } 
Table 2 – UserManagementView class definition 
 
As a daughter class of GenericTreeView, the UserManagementView can use 
its pointer attribute a_pGenericTreeModel to capitalize on all the GenericTreeModel’s 
default programmed services. The same attribute gives access to any customized 
jobs performed by the UserManagementModel. 
In addition, as formerly showed in Figure 32, the UserManagementView 
communicates with the LoginModel. This model contains all information regarding 
the registered users list. It is used in the User Identification module (or simply Login 
module as it is named in Figure 28) by the LoginView to retrieve the necessary data 
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to show the list of registered users (if the login method is set to password verification) 
and to validate either the entered password or the scanned badge code (if the 
method is set to barcode identification).  
In the same way, the UserManagementView requests and receives 
information from this model to display the list on the screen. However, while the 
Login module only analyses that information, comparing to user input, to grant 
access to the machine, the User Management module can, through the LoginModel, 
modify the login data source following user actions. The data source from which/to 
which the LoginModel reads/writes user information is an Extensible Markup 
Language (XML) file. This type of structuration allows for easy, swift and reliable data 
processing.  
Resuming the editing example previously described, after modifying the 
selected user information and pressing the Confirm button (the one with a check icon 
showed in Figure 31) the Save button will be enabled and appear colored (when 
before, as disabled, it was gray). Up until this step the changes made are temporary. 
Pressing the Save button will trigger a function from the LoginModel that will modify 
permanently the information on the data source.  
A view that calls model methods to modify its core directly is the (desirable) 
result of Qt’s strategy of embedding the Controller layer of the MVC pattern in view 
objects. The implementation of the User Management module confirms the 
advantages arisen from the adaptation of the original architecture with regard to 
programming simplicity, as it was discussed in Section 4.1:. 
Similar modules were developed to manage barcode formats and 
configuration parameters. 
 
4.3.2: Mask Management Module 
 
Today, most health provider centers have their own identification and labeling 
systems which means that different code formats must be registered so that each 
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client may choose an appropriate pattern for the machine to expect as a platelet bag 
ID key. The Mask Management module handles the list of possible barcode formats 
otherwise called masks.  
A mask is a mold that serves as a comparison base to verify if the scanned 
code respects a certain set rules. For instance, a fictional French blood bank may 
have a labeling system that generates four digits codes preceded and succeeded by 
the capital letter A for platelet bags that have not yet undergone the THERAFLEX-
UV procedure. A sample bag code would be A1234A. For this system the code 
pattern is simple: six characters, the first and the last a capital A and the middle four 
numerals from 0 to 9. The mask to guard this rule would be “A####A” where the 
hashtag symbol represents a digit. If, after the bag is treated, the fictional system 
expects the same four digit code with a B as prefix and suffix, the Macotronic UV 
application should print a product label with the code “B1234B”. That mask would be 
“B####B”.  
Furthermore, a client may not wish to visualize in the screen a large number of 
letters and symbols that, albeit important for the digital identification system, convey 
little-to-no practical information for the human operator. In this case, it would be ideal 
for the HMI to apply a display filter to hide unwanted characters and exhibit on 
screen only the ones of interest. In the example above if only digits were desired 
both primary and treated bags codes, once scanned, would appear as “1234”. The 
display filter would be a transformation mask defined as “[####[”, where the bracket 
symbol is an order to ignore any characters present in their position. Table 3 
summarizes the symbols used in the masks and their meaning. 
Symbol Signification 
? Any letter from A to Z (both in upper and lower case) 
# Any digit from 0 to 9 
§ Any letter OR any digit 
[ Suppress the character in that position  
Other All other symbols represent themselves including a space  
Table 3 – Masks symbols 
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Printed at the end of an illumination cycle, the product label contains an 
encrypted barcode (e.g. “B1234B”) and, just below it, its equivalent human readable 
code. This code is likewise susceptible to a presentation filter to improve legibility. 
Ultimately, a single product identification system needs a group of four masks as 
defined in Table 4. Still, one platelet bag may contain several different ID keys: 
donation, product and lot codes, each of which may follow different encrypting rules.  
Mask Utility 
Input Entry format for non-treated platelet bags 
Display Screen presentation format 
Barcode Output Barcode format for printed label 
Text Output Human-readable text format for printed label 
Table 4 – Mask batch and specific utilities 
 
A treatment center that receives platelet bags from various blood banks must 
be prepared to accept all alternatives identification codes. This justifies the creation 
of a mask list.   
 
 
 
 
 
 
 
 
Figure 33 - Mask Management View in editing mode  
(Source: own production) 
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Much like for the management of user information, the application’s former 
version required Macopharma’s technicians to register the mask list with an external 
tool during installation, due to the lack of an embedded dedicated tool.  
Profiting from the expandable tree design, the new HMI integrates the Mask 
Management module the same way it integrates the User Management module 
(Figure 33). The MaskManagementView is another subclass of the GenericTreeView 
thus recycling its behavior. Analyzing Figure 32’s diagram, the only substantial 
change between both module’s structure, other than swapping the User 
Management view and model classes for the Mask Management’s, would be the 
connection with the MaskModel instead of the LoginModel. Handling all mask-
pertaining information, the MaskModel manipulates the registered mask list also 
contained in a XML file. 
The reduction in work load for the implementation of the Mask Management 
module derives from the reuse of the GenericTreeView and the GenericTreeModel 
and proves the advantages of a well-thought generic architecture. 
 
4.3.3: Parameter Configuration Module 
 
The correct configuration of the Macotronic UV illumination device is vital to 
guarantee the quality of the platelet treatment and the user experience. The 
prototyped application organized the necessary parameters in an Initialization (INI) 
file that could be opened and edited directly in the Windows system by a 
Macopharma technician during the installation process. If further modifications were 
required at a later time, a technician would need to return, no matter how small the 
alteration.   
Once more the issues related to accessing files outside of the HMI application 
motivated the incorporation of an inlaid parameter management tool. The 
parameters were structured in a XML file and the ParametersModel was 
implemented to handle its data. However, contrarily to the User and Mask 
Management modules, this feature does not allow the addition or removal of 
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parameters, only the modification of their values, observing pre-defined constraints 
and limiting thresholds. Failure to respect any of these restrictions will result in a 
warning message, serviced by the GenericPopupView. 
Since the Parameter Configuration module will only display the parameters’ 
names and values, it was deemed unnecessary the use of the extending tree effect 
to show numerous fields of information. A simple two column table would suffice for 
this module’s presentation (Figure 34). When in editing mode, the second column 
will offer either an option box or an editing field, depending on the parameter’s 
characteristic: if it has a list of pre-determined possible values or not. For entering 
numeric values, the virtual keyboard is at disposal on the right side of the screen 
(serviced by the RightBarView).  
 
 
 
 
 
 
 
 
Figure 34 – Parameters View in editing mode (Source: own production) 
 
Even though there were no predictions for other modules to be depicted in the 
same way, new generic classes (GenericTableView and GenericTableModel) were 
implemented for good measure. In future revisions, if there is the need to include a 
new module with similar characteristics, this course of action would again warrant for 
a decrease in development time and complexity.   
Since the development of this module followed the same principle as the two 
previously examined, this section does not repeat the relational aspects of its 
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components. There is, nevertheless, a particularity to this module worth mentioning: 
not all parameters should be alterable by even an Administrator-level user.  
Although some of the parameters are directly related to user comfort and 
preferences and will not engender problems for the faultless realization of the 
THERAFLEX UV procedure, others are used for hardware setting and are too 
sensible and out of an operator’s field of expertise to be modifiable by a user.  
To ensure that only the right parameters are accessible to users, a “visibility” 
tag was added for each parameter structure in the XML file. This tag can have either 
a “private” or a “public” value to define a parameter visible only to a Macopharma 
technician or to all Administrator-level users, respectively.  
A Macopharma technician can log into the system as the MACO user: a 
special administrator that is always registered and cannot be altered or deleted. The 
Parameter Configuration module has a connection with the LoginModel to inquire 
about the access rights of the logged user. If it is the MACO user logged, the 
ParametersView will show all existing configuration parameters; otherwise (if it is a 
normal Administrator) it will show only the publicly-marked parameters. Operator-
level users cannot access any of said parameters. 
 As it is, when a client wishes to change the time it takes for the application to 
enter the Stand-by mode (power-saving mode), for example, or even wishes to 
completely disable this option, there is no need to call a specialized Macopharma 
technician: an Administrator can modify these parameters directly. On the other 
hand, while modifying these simple configuration elements, there is no risk of this 
user altering the agitation speed set point for the internal tray’s orbital movement 
(critical to a uniform light exposure of the platelet concentrate bag). Clients have 
more autonomy while the application gains in safeness and practicality. 
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4.3.4: Illumination Cycle Module 
 
Launching the illumination cycle is, of course, the most important action a user 
can perform on the Macotronic UV illumination device. The Illumination Cycle module 
comprises many essential features and its structure is better detailed in Figure 35. 
There are three essential views which represent each a major step for performing the 
THERAFLEX UV procedure. 
 
Figure 35 – Illumination Cycle module (Source: own production) 
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The first step is identifying the platelet bag. Figure 36 partitions the 
identification process: after placing the platelet concentrate bag on the internal tray 
(No. 1), the bag’s ID codes are scanned (No. 2) and verified against the chosen 
masks (expected code formats explained in Section 4.3.2:).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 36 – Bag Identification steps (Source: [10] and own production) 
 
The BagIdentificationView displays the scanned codes on the screen (No. 3, 4 
and 5). There may be two or three identification keys to suffer validation depending 
1 2 
4 
5 6 
3 
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on the machine’s settings: while the donation and lot codes are always present (No. 
3 and 4), the product code (No. 5) appears only if so configured (by the parameter 
highlighted in Figure 34). If and when the validation is successfully completed the 
user can push the internal tray into the device closing the machine (No. 6) [10].   
Once the machine is closed the CycleView will be painted on the screen. It 
pictures a progress bar that will initially represent the advancement of the pre-cycle 
tests execution and later will be reset to show the cycle’s own progression. Figure 37 
presents these two situations.  
The HMI’s pre-cycle tests serve mainly to verify if there is enough space left 
for the creation of a new cycle history file and if the device’s sensors’ calibration is 
not outdated. They recover threshold limits from the ParametersModel. In case of a 
test failure the CycleView will alert the user of the need for space maintenance or 
machine recalibration. The connections between the GenericPopupView and both 
CycleView and  BagIdentificationView, which accounts for these warning messages, 
were not included in Figure 35’s diagram for simplicity’s sake. The same can be said 
regarding the communication between these two view classes and the 
BottomBarView (the bottom bar buttons can be seen on both views).  
 
 
 
 
 
     
 
Figure 37 – Cycle View during pre-cycle test (left) and during illumination (right) 
(Source: own production) 
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If the pre-cycle tests are concluded with no errors the CycleView employs its 
model to launch the illumination. The CycleModel works with the MachineModel and 
the CommunicationModel to send commands via serial communication to the 
device’s microcontroller triggering a hardware response (i.e. turn on tray motor and 
UVC lamps) thus starting the THERAFLEX UV procedure.  
While this operation is running, the CycleModel constantly requests sample 
values from the I/O board: bag temperature, tray’s agitation speed, light intensity, 
delivered energy dose (among others). It stores this data and updates the 
CycleView’s progress bar, duration clock and the accumulated light exposure (Figure 
37 on the right). Through the Graph button the view provides the curves of the four 
aforesaid variables. These features grant users with full process monitoring.  
Chapter 5 covers the hardware verifications performed during the cycle by the 
microcontroller software. Here it is enough to point out that if a hardware mal-
function is detected, the cycle will be terminated and an error “popup” message will 
appear to warn users that the treatment was incomplete. The error code and 
description will be stored with the rest of the cycle data. The user can also cancel the 
treatment mid-term by pressing the Stop button, in which case the cycle will be 
considered as incomplete as well. 
Upon receiving an End-of-cycle flag from the microcontroller, regardless of the 
cycle’s status (correctly treated, cancelled or terminated with error), the CycleModel 
signals its view. The CycleView will notify the user of the overall treatment result with 
a green (success: Table 5 - lines 9 to 12), red (suspended: Table 5 - lines 3 to 6) or 
caution (failure: Table 5 - lines 13 to 18) “popup” view all of which are equally based 
on the GenericPopupView class. Next it will requisition the CycleHistoryModel to 
organize the stored data from the CycleModel in a new history file (Table 5 - line 20). 
Based on this file a report and a product label will then be generated and sent to the 
connected printers by the ReportModel and the LabelModel (Table 5 - lines 21 and 
22 respectively).  
To exit the outcome view and enter the BarcodeComparisonView the user 
must touch any part of the screen so acknowledging the end of the illumination 
treatment. This final step serves as a product control stage. Reopening the machine, 
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the user can scan both the original bag codes and the printed code to verify if there 
were no compatibility problems or impression errors. A Label button on the bottom 
bar enables label reprinting in case of visibility damage. Once the comparison is 
validated, the printed adhesive label can be placed on the bag ensuring traceability. 
 Slot executed in the CycleView when the endOfCycle signal is 
emitted by the CycleModel 
001 void CycleView::slt_endOfCycle(bool success) : 
002 { 
003 if (a_pCycleModel->getStatus() == CANCELLED) 
004 { 
005 a_pGenericPopupModel->setStyle(RED); 
006 } 
007 else 
008 { 
009 if (success) 
010 { 
011 a_pGenericPopupModel->setStyle(GREEN); 
012 } 
013 else 
014 { 
015 string error = a_pCycleModel->getErrorDescription(); 
016 a_pGenericPopupModel->setStyle(WARNING); 
017 a_pGenericPopupModel->setDescription(error); 
018 } 
019 } 
020 string filePath = a_pCycleHistoryModel->createHistoryFile(); 
021 a_pReportModel->generateAndPrintReport(filePath); 
022 a_pLabelModel->generateAndPrintLabel(filePath); 
023 } 
Table 5 – End-of-Cycle slot 
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The THERAFLEX UV – Platelets procedure is thus concluded leaving only the 
need to transfer the treated contents from the illumination bag to the storage bag. 
The Macotronic UV device is instantly ready to perform another cycle. 
 
4.4: General State Machine Controller 
 
Now that most modules have been explored individually, the general state 
machine controller can be addressed. This object manages all the application’s 
macro states and the events required to pass from one state to another.  
The Controller makes use of Qt’s State Machine framework that provides 
classes for creating and executing state charts: graphical models of how a system 
reacts to user interaction. Such classes as QStateMachine, QAbstractState, QState, 
QFinalState and QHistoryState as well as their embedded functions and signals/slots 
help to compose and handle the application’s dynamics. Figure 38 shows a 
simplified diagram between these classes and the implemented Controller.  
 
 
 
 
 
 
 
 
 
Figure 38 – Controller class (Source: own production) 
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QAbstractState and consequently all its subclasses, for example, emit a signal 
every time the state has been entered or exited, which proves most useful in 
identifying the moment when a specific behavior should be launched. Usually this 
behavior implies painting a new view on the main window, since a change in state is 
generally accompanied by a change of the screen.  
Functions Actions Performed 
Controller’s constructor 
- called from the main - 
Initializes its members:  
a_pView = new MainView(); 
a_pStateMachine = new QStateMachine(this);  
createStates(); 
Controller::start() 
- called from the main - 
Starts the main window and the state machine: 
a_pView->show(); 
a_pStateMachine->start(); 
Controller::createStates() Creates all states and adds them to the machine: 
a_pInit = new GenericState(); 
a_pLogin = new GenericState(); 
… 
a_pStateMachine->addState(a_pInit); 
a_pStateMachine->addState(a_pLogin); 
… 
a_pStateMachine->setInitialState(a_pInit); 
createTransitions(); 
createBehaviors(); 
Controller::createTransitions() Defines all transitions between states: 
a_pInit->addTransition(a_pView, SIGNAL(sig_event()), 
a_pLogin); 
… 
Controller::createBehaviors() Connects enter-state signals to correct slots: 
connect(a_pInit, entered(), SLOT(enterInitView())); 
connect(a_pLogin, entered(), SLOT(enterLoginView())); 
… 
Table 6 – Controller’s main functions 
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QState offers an addTransition() function that associates the current state, a 
signal and its sender to a target state. In other words, it creates a transition between 
the present state and the target state that will occur only when a given signal emitted 
by a particular object is received. 
The GenericState class inherits from QState and includes variations of the 
addTransition() function, allowing the event created to be conditional upon the 
signal’s argument. This way, the same signal can trigger transitions to different target 
states depending on its parameter.    
Ultimately when a transition-associated signal is received and the machine 
changes state the targeted state emits a entered() signal which in turn is connected 
to a slot carrying the desired behavior. Table 6 contains the Controller’s main 
functions and reflects this dynamic.  
Slot called when a_pInit state is entered: portrays InitView 
001 Controller::slt_enterInitView()  
002 { 
003 a_pView->setView(NULL, CENTRAL); 
004            a_pView->setView(NULL, RIGHT); 
005            a_pView->setView(NULL, BOTTOM); 
006 a_pView->setView("InitView", FULL); 
007 } 
Table 7 – Enter-Initialization-View slot 
Slot called when a_pLogin state is entered: portrays LoginView 
001 Controller::slt_enterLoginView()  
002 { 
003 a_pView->setView("LoginView", CENTRAL); 
004            a_pView->setView("RightBarView", RIGHT); 
005            a_pView->setView("BottomBarView", BOTTOM); 
006 a_pView->setView(NULL, FULL); 
007 } 
Table 8 – Enter-Login-View slot 
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Tables Table 7 and Table 8 hold the implementation of the slots related to the 
states exemplified in Table 6: a_pInit and a_pLogin. When the first state is entered 
the InitializationView will be painted on the screen, occupying the whole MainView 
(Table 7 - line 6). As for when the second state is entered the LoginView will be set 
in the central area of the MainView (Table 8 - line 3), while the RightBarView and the 
BottomBarView will be set respectively on the right side and bottom widgets (Table 8 
- lines 4 and 5). So far as no other state-changing events occur, the view class will 
assume the management of its visual features while the affiliated models will be 
responsible for their tasks. 
Finally, Figure 39 shows a simplification of the chart draw up to organize and 
sequence the Macotronic UV application’s states (in blue) and operations (in green). 
It defines the user-based and other events that serve as transitions (arrows) between 
states focusing on the steps to reach the illumination cycle. In order to summarize 
the graph, other states are simply listed in blue (inside the MenuView) to show that 
they are featured in the system, rather than detailed in separate boxes. 
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Figure 39 – Macotronic UV’s State Machine (Source: own production) 
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Chapter 5. Microcontroller Software 
The Macotronic UV illumination device contains several actuators and 
sensors: six UVC lamps to illuminate the platelet bag; a relay to switch the lamps on 
or off; a motor to agitate the internal tray thus supplying the orbital movement 
needed for uniform light exposure; four photodiodes to detect and quantify the light 
intensity delivered to the bag; motors to turn on ventilators and cool the machine 
down; a motor to move up or down the front panel door; end position sensors to 
verify the door’s and tray’s placements; and a pyrometer to read ambient and 
targeted temperature.  
Embedded in an analog I/O board (Figure 40) from Digi International’s high 
performance BL4S200 series, the Rabbit® microcontroller provides fast data 
processing. Its dedicated IDE called Dynamic C accounts for powerful 
programmability in software development. This chapter focuses on the implemented 
program that manages the above enumerated components. 
 
 
 
 
 
 
 
 
Figure 40 – BL4S200 I/O board with the Rabbit® microcontroller 
(Source: [7]) 
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To present the basic overall construction of the software Table 9 contains the 
pseudo-code from its main() function. After configuring all digital and analogical 
inputs and outputs from the I/O board (line 3) the microcontroller continuously reads 
the photodiodes’ data (line 6), verifies and executes any commands sent by the HMI 
application (lines 7 and 8) and communicates with the pyrometer if necessary (line 
9). This fundamental structure has not been modified during the software’s revision. 
Microcontroller software in C: main function 
001 void main() 
002 { 
003 initilializeIOBoard(); 
004            while(true) 
005 { 
006 acquirePhotodiodesMeasurements(); 
007 communicationCPU(); 
008 generalStateMachine(); 
009 communicationPyrometer(); 
010 } 
011 } 
Table 9 – Microcontroller’s main function 
 
Between the former and the new versions of the software the most significant 
modification was the change in the operating mode regarding the illumination cycle.  
Originally each action needed to perform a cycle (start tray agitation, turn the UVC 
lamps on, etc.) was executed individually following direct requests issued by the HMI 
application: one request equals one action. Currently a single command can set off a 
chain reaction that will be completely handled by the microcontroller’s state machine. 
This was accomplished by adding new states (notably the Pre-cycle, Cycle and Stop 
Cycle states pictured in Figure 41), defining their tasks and determining the 
transitions between them.  
Other states were not depicted in Figure 41 simply because no modifications 
were made concerning them. Although some are obsolete when this program version 
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is deployed along with the new HMI software, they were maintained to guarantee 
compatibility with the previous versions and with diagnostically important internal 
applications.  
 
Figure 41 – Microcontroller’s General State Machine (Source: own production) 
 
Upon reception of the “Start Cycle” command sent from the CPU the 
microcontroller will check if the tray is well positioned inside the device and if the 
front panel door is up and closed. In case these pre-conditions are met, the machine 
will be set to the Pre-cycle state, which is responsible for executing hardware tests 
before the start of the cycle to ensure there are no problems of communication with 
the pyrometer, that the machine’s temperature is at an acceptable value and that all 
UVC lamps are turned off (thus not already emitting light which would not be 
considered in the final delivered energy dose, compromising its precision). 
A failure in only one of these verifications is enough to change the machine’s 
state back to Idle, preventing the illumination process from happening. If, however, 
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all tests are successfully concluded the next state is attained. The Cycle state will 
activate the tray motor, starting the orbital movement. It will verify agitation stability 
issues to increase device and user safety. Once speed consistency is reached, the 
UVC lamps will be turned on, officially decreeing the start of the THERAFLEX UV 
treatment.  
Other hardware verifications will be regularly performed for the whole duration 
of the cycle. These tests serve to detect disturbances, disruptions, sudden collapses 
or incapability among other issues that may befall the device’s components. They 
are briefly explored in the next sections. In the event of an error the machine will 
pass to the Stop Cycle state, terminating the treatment before its conclusion.  
As long as no problems are uncovered and at each passage through the 
Cycle state, an examination of the cumulated delivered energy dose will also be 
executed in order to identify the end of the procedure. When an ideal energy dose is 
achieved, the treatment is considered complete and the Stop Cycle state takes over, 
turning the UVC lamps off, deactivating the agitation motor, opening the front panel 
door and ejecting the tray. Lastly, it will return the state machine to its idle status to 
wait for new cycles. 
After triggering the illumination procedure, the only other interaction with the 
HMI will be answering its request for sample values during the cycle. This section 
does not linger in the particulars of the HMI-microcontroller relationship, since they 
are covered later in this chapter. 
 
5.1: Cycle Tests 
 
Previously performed by the HMI application, the tests were included in the 
microcontroller software to optimize the process and decrease the constant message 
flow between the CPU and the microcontroller. These verifications compose a sub 
state machine where each test is represented by a state, as shown in the right side 
of Figure 41.  
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Usually a test consists of comparing sensor measurements to reference 
values entered as parameters. The blueprint of the tests’ basic operation can be 
observed in Table 10. Handled by the HMI application as discussed in Section 4.3.3:, 
the mentioned parameters are sent from the CPU to the microcontroller at machine 
start-up to configure set points and thresholds.  
The sub state machine for the execution of the cycle tests 
001 void cycleTests() 
002 { 
003 switch(test) 
004            { 
005 case CYCLE_DURATION: 
006 { 
007 if ((currentTime - cycleStartTime) > maxCycleDuration) 
008 { 
009 cycleError = CYCLE_DURATION_ERROR; 
010 } 
011 test = COMM_PYRO;  
012 break; 
013 } 
014 … 
015 } 
016 } 
Table 10 – Basic structure of a cycle test 
 
If the measurements are found to be out of the expected range the test fails 
and an error code specific to the problem is registered in a variable. The same 
variable is monitored by the general state machine to terminate the illumination cycle 
in case of a fault. The error code is sent to the HMI application so it can show a 
description of the problem to the user (see Table 5 lines 15 to 17 in Section 4.3.4:). 
This facilitates diagnostics and decreases the maintenance team’s work load.  
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5.1.1: Cycle Duration 
 
As the simplest test on the list, this verification compares the time elapsed 
since the beginning of the cycle, when the UVC lamps are turned on, to the maximal 
duration value. It is used as an example in Table 10. A cycle too long reflects a 
problem reaching the illumination dose: maybe not all lamps were properly switched 
on or the lamps are not emitting enough light.   
 
5.1.2: Pyrometer Communication 
 
The device’s existing pyrometer is a non-contact infrared thermometer of the 
Optris® CS series. It calculates the surface temperature of an object based on its 
emitted infrared energy. It is a sensitive optical system with a housing made of 
stainless steel that contains the complete sensor electronics. To supply the 
measured temperature values, it communicates with the microcontroller by means of 
a bidirectional RS232 connection [8]. 
Using its own communication protocol, defined in its Operators Manual [8], a 
command is sent through the serial line to request the targeted object’s temperature: 
in this case the object is the platelet bag. If there is a problem with the 
communication, for example the command is either not received or not treated by the 
pyrometer, this test fails. Otherwise the sub state machine switches to the next test 
which will use the value provided by the sensor.  
 
5.1.3: Bag Temperature  
 
The platelet concentrate bag is stored in low temperatures for preservation. 
However, for the THERAFLEX UV procedure to achieve its goal, the bag must be 
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warmed before undergoing illumination. The energy emitted during the process 
undoubtedly heats the bag (up to 2 ºC more than its initial temperature), but 
overheating can irreversibly damage platelet structure. With this in mind it is evident 
that the platelet bag’s temperature must stay within an interval delimited by a minimal 
and maximal threshold (normally 18 ºC and 32 ºC respectively).  
The test converts the value received from the pyrometer to a temperature in 
degrees Celsius and examines if the result is inside that interval. Table 11 shows the 
conversion rule as it is given in the Optris® CS Operators Manual [8]. While this test 
compares the targeted object calculated temperature, the Machine Temperature pre-
cycle test, present in Figure 41, uses the value read from the pyrometer’s head and 
interprets it as the Macotronic UV device’s ambient temperature. 
Pyrometer’s answer Result in ºC 
Target Temperature (bag): byte1byte2 (byte1 x 256 + byte2 - 1000) / 10 
Head Temperature (machine): byte1byte2 (byte1 x 256 + byte2 - 1000) / 10 
Table 11 – Conversion equations for bag and machine temperature 
 
5.1.4: Photodiodes Light On  
 
This test verifies that all UVC lamps are functioning correctly by comparing the 
measurements of each photodiode to a value that defines the minimal amount of 
light emanation needed to consider a lamp as turned on. Due to the lamps’ and 
photodiodes’ dispositions, if a particular set of values is found to be under the 
determined limit, the photodiodes implicated indicate which lamp is likely turned off.  
The Dynamic C library provides an inlaid function to read analogic inputs and 
transform them into digital information. This function is called to acquire the 
photodiodes’ data converting its 0 – 10 V entries to a 0 – 2047 nondimensional range 
[7]. Before performing the verification the test has to process the data into mW/cm²: 
the unit in which the reference values sent by the HMI application are given. Since 0 
– 10 V is equivalent to 0 – 100 mW/cm² [9] the transformation rule is: 
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This equation is used every time the values read by photodiodes are needed 
in a calculation to perform a test (as is the case in all verifications described in the 
following sections). 
 
5.1.5: Light Intensity  
 
To guarantee a stable illumination, this test verifies if the emanated light 
intensity is comprised in a set scope. It calculates the average of all photodiode-
acquired values and compares it to the interval’s boundaries. If the average falls 
outside the limits it is recalculated with newly measured values until either the 
comparison succeeds or a timeout occurs. The test fails if and when the timeout 
occurs; meaning that for a certain period of time the average light intensity was 
constantly out of scope.   
 
5.1.6:  Blinking Lamps 
 
As its name suggests, this test detects flickering lamps. To do so, it calculates 
a ratio between the current and the preceding measurements for each photodiode 
and compares it to a referenced tolerance. Significant discrepancies between 
present and previous acquisitions result in a high ratio value and indicate that a lamp 
is shining intermittently or unsteadily. Every time the ratio is greater than the 
tolerance an error counter is incremented and the comparison is repeated with 
freshly procured values. A successful comparison implies a reset of the error 
counter. To prevent raising a false alarm owing to acquisitioning problems, the test 
will only fail if the error counter reaches a parameterized number, denoting 
measurement in mW/cm² = photodiodeValue * 100 / 2047 
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consecutive variance. Again, the photodiodes affected pinpoint which lamp is mal-
functioning. 
 
5.1.7: Sensor Disparity 
 
In order to identify faulty photodiodes this test compares the measured values 
of each photodiode individually with the average of all values. Disparities more 
substantial than the pre-defined tolerance range uncover an issue with the 
photodiode’s sensing capacities.    
 
5.1.8: Dose Control 
 
Contrarily to previously visited tests, this control does not detect hardware 
related problems, but rather serves to ascertain the end of the illumination cycle. It 
calculates the accumulated light intensity by adding at every pass the former to the 
current delivered energy dose. The dose is computed with the multiplication of the 
photodiodes’ average and the time elapsed since the last calculation took place. 
The Stop Cycle state is attained once the cumulated dose reaches or 
surpasses the set point. This state will turn the UVC lamps off and stop the tray’s 
agitation as described in the first section of this chapter. Seen as the lamps take a 
little time to completely stop emanating light, another test is performed to inspect the 
photodiodes’ acquisitions (in case they are still pick up any input signals) and 
eventually consider the residual light, verifying that in total the delivered dose does 
not exceed a maximal threshold, which could endanger platelet structure and 
functionality and invalidate the whole procedure. 
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5.2: Communication Protocol 
 
The interactions between the HMI application and the microcontroller are 
accomplished with a RS232 serial connection through which messages containing 
characters in the American Standard Code for Information Interchange (ASCII) are 
exchanged. Table 12 shows the main configuration characteristic for the 
communication interface [11].  
Communication Protocol Configuration 
Baud rate 115200 bauds 
Data bits (per character) 8 bits 
Parity None (N) 
Stop bits 1 bit 
Flow control Off 
Table 12 – Serial connection settings 
 
Being a bridge between the two software components of the Macotronic UV 
device it stands to reason that the communication protocol is build based on tasks 
performed by both of its ends. As it was conceived for the prototype version, the 
CPU board serves as a master while the I/O board is considered the slave. In 
practice this means that the microcontroller can only respond to requests from the 
HMI and not pro-actively send messages to the application. 
On the HMI’s side, the CommunicationModel employs a QSerialPort object 
(provided by Qt) to find the correct serial port and set it with Table 12’s parameters. It 
then stablishes a connection by opening this port. It is also responsible for 
constructing and sending demand frames to the I/O board. At the other extremity the 
microcontroller software will read these demands and inspect the data’s structure 
before executing the commands and returning the awaited answers.  
The transited frames’ composition follows a defined and unchangeable 
arrangement (Table 13): a start byte to determine the beginning of the frame; a 
command byte consisting of the request’s identification key; optional data bytes to 
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eventually supply the microcontroller with important information; a checksum byte 
that varies according to the precedent bytes’ values and is used to detect accidental 
changes in data; a stop byte to recognize the end of the transit container.  
Name Representation Hex - Dec Example: Ping cmd 
Start byte : 3A - 58 : 
Command byte CC  (variable) 30 
Data bytes (optional) DD (variable) 01020304 
Checksum byte (CRC) XX (variable) 12 
Stop byte (CRLF) \r\n DA - 218 \r\n 
Table 13 – Command basic structure 
 
A Cycle Redundancy Check (CRC) code was used as the checksum byte 
because it is simple to implement in binary hardware, easy to analyze mathematically 
and particularly efficient at uncovering common errors caused by noise in 
transmission channels. The CommunicationModel calculates a fixed-length CRC 
value based on the command byte and eventually the data bytes and appends it to 
the message as a redundancy: it expands the message without really adding new 
information to it).  
Upon reception of a frame, the microcontroller software will initially ascertain if 
the first and last byte correspond respectively to a “:” and a “Carriage Return - Line 
Feed” (CRLF) character. If the start and stop bytes are validated, a corroboration of 
the CRC value will take place: the received data is used to calculate a fresh CRC 
which is then compared to the received checksum byte. In case of a match the 
message’s integrity is ensured and the command can be executed, otherwise an 
error code is sent back to the CPU. Other errors may occur during frame treatment 
producing different responses: Table 14 presents the possible resulting codes. 
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Name ID (Hex) Function 
ACK_SUCCESS 0x0F No error found during data processing 
CHECKSUM_ERROR 0xF2 No match of CRC values 
CMD_UNKNOWN 0xF3 Command identifier unknown 
FRAME_SIZE 0xF4 Frame size differs from expected 
Table 14 – Possible acknowledgement messages 
 
Both the HMI’s and the microcontroller’s programs have an equivalent list of 
identification codes for the exchangeable requests. Considering the alterations in the 
operating mode explored in earlier in this chapter, new ID keys were included in 
these lists. The Ping command, exemplified in Table 13, was added so that the 
application could continuously verify the status of the connection (no reply received 
indicates communication failure). The implications of the other requests listed in 
Table 15 have been described in the beginning of the present chapter. 
Name ID Function 
PING 30 Questions if microcontroller is listening 
CONFIG 31 Set reference values for cycle (tests and set points) 
START_CYCLE 32 Trigger cycle’s chain reaction (pre-tests, agitation, illumination)  
CYCLE_SAMPLE 33 Request sample values from illumination cycle 
STOP_CYCLE 34 Terminates cycle forcibly (user’s cancel cycle action) 
Table 15 – Added commands 
 
Although the new HMI application still profits from some other commands, 
notably the ones to open/close the front panel door and eject/insert the tray, most of 
the original requests became obsolete for this revision’s operation. However, to 
maintain compatibility with former versions and to allow a connection between the 
microcontroller and a diagnostics application – called UVC Test and developed in 
parallel by another member of the Automation’s team – all the existing demands and 
their consequent actions were kept intact in the microcontroller’s software.  
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Chapter 6. Conclusions 
The Macotronic UV project was carried out to reengineer the embedded 
system of the prototype version, improving user comfort, enhancing code 
maintainability, optimizing process control and increasing the illumination precision, 
thus achieving overall higher quality levels for the THERAFLEX UV-Platelets 
pathogen inactivation procedure.  
 Taking into account client feedback, a completely new Human-Machine 
Interface was developed. This application, focused in sophisticated looks and user-
friendly, intuitive features, aimed to simplify tasks and, with its inlaid configuration 
tools, avoid problems arisen from installation errors. The software was designed with 
a modular architecture in order to facilitate future revisions and reduce maintenance-
related efforts. The graphic arrangement, however, has yet to be validated by 
Macopharma’s Marketing department.    
 The modifications made in the microcontroller’s operating mode allowed for a 
single user command to trigger a sequential flow of actions needed to perform an 
illumination cycle.  
With fewer messages exchanged between the CPU and the I/O boards and 
by locally calculating the cumulated delivered energy dose, the microcontroller 
software renders a more accurate illumination with regards to the total light intensity 
required to inactivate leukocytes and pathogens present in the platelet concentrate 
bag without damaging platelet structure and function. The internal hardware 
verifications currently executed by the microcontroller speeds the detection and 
identification of components’ failures and no longer require direct interaction with the 
main application. 
To accommodate the aforementioned changes in operation, the 
communication protocol between the user interface and the microcontroller software 
was adapted and new requests were included. Nevertheless this interface remained 
otherwise intact to prevent compatibility issues with previous versions of the system.  
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During the development of the Macotronic UV project, all software 
implementations followed internal standardizations and good programming practices 
provided by the Automation department’s quality guides. 
 Although at each development stage the corresponding tests were performed 
to assess if the implemented features respected the associated specifications, a 
global validation will take place before the official release of the Macotronic UV 
embedded system’s new version.  
 Due to the short time of the internship, there are still some features to be 
implemented before the project’s completion, notably the hardware auto-tests that 
must be executed during the machine's start-up to ensure that all the device’s 
components are active and ready to use. There are also finishing touches and 
program adjustments to be made to achieve an increase in code robustness.   
 Finally this project represents the first step in releasing an innovative machine 
that can potentially help health providers around the world to deliver a purer and 
safer treatment for those in need of platelet transfusion.  
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